There have been debates and investigations on the clinical benefit and adverse effects of the traditional Chinese medicines used for the treatment of COVID-19 \[[@bib0005], [@bib0010], [@bib0015]\]. The answers to these questions require a more comprehensive mechanistic understanding and clinical evaluation of these traditional medicines. As part of the efforts for probing these questions, the possible mechanisms of these traditional Chinese medicines have been studied based on the experimental and predicted targets of the chemical ingredients, which have been derived from the liquid chromatograph-mass spectrometry \[[@bib0020]\] and obtained from literature surveys \[[@bib0025],[@bib0030]\].

These studies have shown that the knowledge of the chemical ingredients of the traditional Chinese medicines are highly useful for COVID-19 investigations. In particular, the knowledge and clinical profiling of the activities of the chemical ingredients enables the multi-omics studies for finding the clinically-relevant targets \[[@bib0015]\], and the molecular structures of the chemical ingredients are needed for molecular docking and target binding studies in target assessment \[[@bib0025]\]. Additionally, the knowledge of the chemical ingredients facilitates the molecular and disease network analysis with respect to the experimental and predicted targets for understanding the network pharmacology \[[@bib0020]\], and the statistical frequency of appearance analysis of the literature-reported chemical ingredients and mechanisms for focusing on the high confidence mechanisms \[[@bib0030]\].

The mechanisms of the traditional Chinese medicines are multifaceted in general and for the treatment of COVID-19 in particular \[[@bib0005],[@bib0010],[@bib0025],[@bib0030]\]. Therefore, more comprehensive investigations are needed for understanding the mechanisms of these traditional Chinese medicines, and for unveiling their benefits and adverse effects. A key step towards such investigations is to obtain the chemical ingredients of these traditional Chinese medicines, particularly the molecular structures and activities. In addition to the literature surveys \[[@bib0025],[@bib0030]\], it is of interest to explore the rich resources of the open-access natural product (NP) and traditional medicine databases for the relevant information, particularly the molecular structures of the chemical ingredients and the activity-related information useful in the investigations of the traditional Chinese medicines against COVID-19.

Two open questions can be raised: to what extent these databases provide the molecular structures of the chemical ingredients of the traditional Chinese medicines used for the treatment of COVID-19, and what activity-related information is provided for facilitating the mechanistic investigations. These questions were probed by a database search investigation with respect to 24 traditional Chinese medicines recommended by the National Health Commission of China \[[@bib0005],[@bib0015],[@bib0030]\], using the names of the constituent herbs of each medicine. The searched NP databases include SuperNatural II, UNPD, ZINC, and NPB (http://www.npbdb.net:8080) databases, which provide comprehensive molecular structures, physicochemical properties, vendors, annotations (e.g. literature reported activities and mechanisms), and predicted properties (e.g. toxicity classes) for 325,000, ∼229,000, ∼80,000 and ∼444,669 NPs respectively. The searched traditional Chinese medicine databases include TCM-ID, TCM\@Taiwan, TCMID, TCMSP and SymMap with ∼7,400, ∼33,000, ∼18,200, ∼13,000 and ∼19,595 NPs respectively, which provide comprehensive information on the molecular structures of the chemical ingredients, constituent herbs, prescriptions, and activity information (e.g. experimental and predicted targets or activities, NP-target relationships, and the clinical gene expression profiles of the NP targets). Moreover, a database TM-MC (∼24,000 NPs) provides comprehensive data on the traditional medicines from Northeast Asia (Korean, Chinese, and Japanese).

Our search results ([Table 1](#tbl0005){ref-type="table"} ) showed that most of the searched NP databases provide insufficient species information for searching the chemical ingredients of the traditional Chinese medicines, with the exception of the NPB database. The NPB database provides species information for 10 disciplines and the molecular structures for ∼444,669 NPs. All major traditional medicine databases support the convenient search and provide molecular structure and activity-related information for high numbers of the chemical ingredients of the 24 traditional Chinese medicines, with the exception of the TCM\@Taiwan database that has been inaccessible during our search investigation. Significantly, each of these databases covers the molecular structures of 49-3,869 chemical ingredients for each traditional Chinese medicine ([Table 1](#tbl0005){ref-type="table"}). In particular, the NPB database provides the molecular structures of the highest numbers of chemical ingredients for 91.7 % of the 24 traditional Chinese medicines.Table 1The traditional Chinese medicines (TCMs) recommended by the National Health Commission of China, the number of chemical ingredients of each TCM searchable from the major databases of traditional medicines and natural products, and the main features of each database useful for mechanistic investigations.Table 1COVID-19 clinical casesTraditional medicine for COVID-19 treatmentDatabaseTCM-IDTCMIDTCMSPTM-MCSYMMAPNPBDatabase main features useful for COVID-19 investigationsIntegrated TCM data, exp targets, clinical target profileIntegrated TCM data, exp and predicted targets, activities, diseasesTCM systems pharmacology data, exp and predicted targets, target and disease networksNorth eastern Asia traditional medicinesIntegrated TCM data, symptoms, exp and predicted targets, networks of herbs, symptoms, targets and diseasesLargest natural product database for 10 disciplines, predicted targets or activitiesNumber of chemical ingredients in databaseMedical observation periodFatigue with gastro-intestinal discomfortHuoxiang Zhengqi capsules\
藿香正气胶囊7789071045135017452,347Fatigue with feverLianhua Qingwen capsules\
连花清瘟胶囊7337901312160516273084Jinhuaqinggan granula\
金花清感颗粒496819834109711802215Shufengjiedu capsules\
疏风解毒胶囊4735711004132210411762Clinical treatment periodMild casesHanshi Yufei Formula\
寒湿郁肺证处方74310551256172414132042Shire Yunfei Formula\
湿热蕴肺证处方6689301274145415412699General casesShidu Yufei Formula\
湿毒郁肺证处方5496281021138612472185Hanshi Zufei Formula\
寒湿阻肺证处方561836840107110661170Severe casesHuashi Baidu Formula\
化湿败毒方7388631213142514812572Qiying Liangfan Formula气营两燔证处方46367177096110501688Xiyanping Injection\
喜炎平注射液5576499589179Critical casesSuhexiang pill\
苏合香丸45779669310278731596Angongniuhuang pill\
安宫牛黄丸2584565055856091102Neibi Waituo Formula\
内闭外脱证处方347451463574423627Shenfu Injection\
参附注射液76113137174491597Shengmai Injection\
生脉注射液219237200240644590Shenmai Injection\
参麦注射液856274106249349Recovery periodFeipi Qixu Formula\
肺脾气虚证处方555745833109114401956Qiyin Liangxu Formula\
气阴两虚证处方7058551064135815022570Mild, general, severe and critical casesQingfeipaidu decoction\
清肺排毒汤100112421850222121043869Severe and critical casesXuebijing Injection\
血必净注射液4166227287921064868Xingnaojing Injection\
醒脑静注射液146303328346361451Reduning Injection\
热毒宁注射液2273424215166881029Tanreqing Injection\
痰热清注射液2362754826215231201

These databases also provide a variety of the activity-related information useful for mechanistic investigations ([Table 1](#tbl0005){ref-type="table"}). Specifically, TCM-ID provides experimental targets and the clinical gene expression profiles of the targets. TCMID gives experimental targets and predicted targets (by chemical structure similarity), activity values, and the profiles of the related drugs and diseases. TCMSP includes the experimental targets and predicted targets (by SysDT software), and the derived ingredient-target networks and associated target-disease networks. SymMap gives the experimental targets and predicted targets (by SysDT software), and the ring networks of herbs, TCM symptoms, modern medicine (MM) symptoms, ingredients, targets and diseases. NPB provides the predicted targets or activities (by chemical structure similarity).

Collectively, these traditional medicine and natural product databases are highly useful sources of the chemical ingredient data and activity information for facilitating the mechanistic investigations of the traditional medicines against COVID-19.
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